Author(s):
Natarajan K, Subashkumar R
Email(s):
rsubashkumar@gmail.com.
DOI:
10.52711/0974-360X.2023.00763 
Address:
Natarajan K1, Subashkumar R2*
1Department of Biomedical Engineering, Vinayaka Mission’s Kirupananda Variyar Engineering College, Vinayaka Mission’s Research Foundation (Deemed to be University), Salem – 636308, Tamil Nadu, India.
2Department of Biotechnology, Sri Ramakrishna College of Arts and Science, Coimbatore - 641006, Tamil Nadu, India.
*Corresponding Author
Published In:
Volume - 16,
Issue - 10,
Year - 2023
ABSTRACT:
Serratiopeptidase is an extracellular enzyme produced by Serratia marcescens and possesses anti-in?ammatory, analgesic, anti-atherosclerotic, anti-edemic, and thrombolytic properties. The objective of this study was to produce and characterize the serratiopeptidase from environmental isolates of Serratia marcescens. Serratia marcescens strains were isolated from soil samples by spread plate technique and identified by 16S rRNA-PCR assay. Trypticase soy broth was used as the production medium and the crude enzymes were prepared from the culture by centrifugation. The protein in the crude extract was measured by Lowry’s method. Further, the enzyme was purified by column chromatography, and the fractions were concentrated using ice-cold acetone. Serratiopeptidase in the fraction was confirmed by SDS PAGE and characterized for thrombolytic activity on human blood sample. 150 soil samples were processed and 21 isolates of Serratia marcescens were identified. The protein content in the crude enzyme preparation was estimated in the range of 9 to 12.4mg/mL. SDS PAGE of the purified serratiopeptidase produced a distinct band with a molecular weight of 52 kDa. The significant thrombolytic activity produced by 15 isolates and the isolate, SM24 shows the maximum thrombolytic activity of 95%. In this study, serratiopeptidase produced from the isolates of Serratia marcescens shows significant thrombolytic activity on the human blood clot.
Cite this article:
Natarajan K, Subashkumar R. Synthesis and Characterization of Thrombolytic Serratiopeptidase from Environmental Isolates of Serratia marcescens. Research Journal of Pharmacy and Technology 2023; 16(10):4698-2. doi: 10.52711/0974-360X.2023.00763
Cite(Electronic):
Natarajan K, Subashkumar R. Synthesis and Characterization of Thrombolytic Serratiopeptidase from Environmental Isolates of Serratia marcescens. Research Journal of Pharmacy and Technology 2023; 16(10):4698-2. doi: 10.52711/0974-360X.2023.00763 Available on: https://rjptonline.org/AbstractView.aspx?PID=2023-16-10-33
REFERENCES:
1. De la Fuente M, et al. Enzyme therapy: Current challenges and future perspectives. International Journal of Molecular Sciences. 2021; 22(17):9181.doi:10.3390/ijms22179181
2. Jadhav SB, et al. Serratiopeptidase: Insights into the therapeutic applications. Biotechnology Reports. 2020; 28(e00544): e00544.doi:10.1016/j.btre.2020.e00544
3. Bhagat S, et al. Serratiopeptidase: a systematic review of the existing evidence. International Journal of Surgery. 2013;11(3): 209-217.doi:10.1016/j.ijsu.2013.01.010
4. Archana L, et al. Extraction of Serralysin: A Fibrinolytic enzyme from Serratia sp. isolated from soil. Research J. Pharm. and Tech. 2018;11(7):2911-2913. doi:10.5958/0974-360X.2018.00536.X
5. Dhanalakshmi S, et al. Development and Optimization of Natural Colourant from Microbial Pigment. Research J. Pharm. and Tech. 2019;12(7):3475-3478.doi:10.5958/0974-360X.2019.00589.4
6. Namratha K, et al. A study on extraction and characterization of natural red pigment from a soil isolate Serratia marcescens CN14. Research Journal of Pharmacy and Technology. 2022; 15(1):148-2.doi:10.52711/0974-360X.2022.00024
7. Rawat M, et al. An Overview of Miracle Enzyme- Serratiopeptidase. Research J. Pharm. and Tech. 2008;1(3):124-131.
8. Zhao D. Epidemiological features of cardiovascular disease in Asia. JACC: Asia. 2021;1(1),1-13. doi:10.1016/j.jacasi.2021.04.007
9. Tough J. Thrombolytic therapy in acute myocardial infarction. Nurs Stand. 2005;19(37):55-64; quiz 66.doi:10.7748/ns2005.05.19.37.55.c3878
10. Monisha V, et al. Screening for Streptokinase producing Streptococcus sp. from Food and Soil samples. Research J. Pharm. and Tech, 2018;11(7):2845-2847.doi:10.5958/0974-360X.2018.00524.3.
11. Tiwari M. The Role of Serratiopeptidase in the Resolution of Inflammation. Asian Journal of Pharmaceutical Sciences. 2017; 12(3):209-215.doi:10.1016/j.ajps.2017.01.003.
12. Sambrook J, et al. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, New York. 2001
13. Lowry OH, et al. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry. 1951;193(1):265-75
14. Morita Y, et al. Purification and characterization of a cold-active protease from psychrotrophic Serratia marcescens AP3801. J Amer Oil Chem Soc. 1997;74:1377-1383.doi:10.1007/s11746-997-0240-8
15. Gopinath S, et al. Enhancement of Serrapeptase Hyper Producing Mutant by Combined Chemical and UV Mutagenesis and its Potential for Fibrinolytic Activity. J Pure Appl Microbiol. 2020;14(2):1295-1303. doi:10.22207/JPAM.14.2.25
16. Salarizadeh N, et al. Purification and characterization of 50 kda extracellular metalloprotease from Serratia sp. ZF03. Iran J Biotechnol. 2014;12:18-27.doi:10.15171/ijb.1009.
17. Mohankumar A, KrishnaRaj RH. Production and Characterization of Serratiopeptidase Enzyme from Serratia Marcescens. International Journal of Biology. 2011;3(3): 3951.doi:10.5539/ijb.v3n3p39.
18. Patel P, Rabadiya B. New Visible Spectrophotometric Method for Estimation of Serratiopeptidase from Tablet Formulations. Asian J. Research Chem. 2010; 3(3): 631-633
19. Alpesh BL, et al. Development and Validation of Analytical Method for Simultaneous Estimation of Diclofenac potassium and Serratiopeptidase in Pharmaceutical Formulation. Research J. Pharm. and Tech. 2014;7(6): 655-659.